Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study

• Published in: Journal of obstetrics and gynaecology 2020-01, Vol.40 (1), p.96-101
• Main Authors: Advani, Kamal, Batra, Madhulika, Tajpuriya, Sangeeta, Gupta, Rajani, Saraswat, Alka, Nagar, Hemant D., Makwana, Laljee, Kshirsagar, Sarika, Kaul, Pushpa, Ghosh, Asim Kumar, Pradhan, Sandhya, Mehta, Ami, Jaiswal, Anil, Nakhate, Kartik T., Kamdi, Sandesh
• Format: Article
• Language: English
• Subjects: Antioxidants; Combination therapy; infertility; inositols; Insulin resistance; ovulation; PCOS; Polycystic ovary syndrome
• ISSN: 0144-3615; 1364-6893
• DOI: 10.1080/01443615.2019.1604644

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders in women of both developed and developing countries. It is associated with insulin resistance, hyperinsulinemia, hyperandrogenism, oxidative stress and various long-term complications. The present study was undertaken to evaluate the efficacy and safety of the supplementation (Trazer F Forte TM -CORONA Remedies Pvt. Ltd.) providing combination of insulin sensitising agents (myo-inositol, D-chiro-inositol and chromium picolinate), antioxidants (N-acetylcysteine and lycopene) and vitamins (vitamin D, biotin and folic acid) in women with PCOS. After 12 weeks of supplementation, a significant improvement was observed in menstrual cyclicity, acne and hirsutism in both obese and lean PCOS patients. A significant reduction was observed in body weight and BMI of obese subjects. However, both parameters remain unchanged in lean subjects. We suggest that combination therapy of insulin sensitising agents, antioxidants and vitamins may be a fruitful approach for the management of PCOS. Impact statement What is already known on this subject? Monotherapy of insulin sensitising agents, antioxidants and vitamins is beneficial in the treatment of PCOS. What do the results of this study add? Combined use of insulin sensitising agents (myo-inositol, D-chiro-inositol and chromium picolinate), antioxidants (N-acetylcysteine and lycopene), and vitamins (vitamin D, biotin and folic acid) is safe and effective in obese and non-obese women with PCOS. What are the implications of these findings for clinical practice and/or further research? Since PCOS is a multifactorial and a complex endocrine disorder, combination therapy can be used for the comprehensive management of PCOS.